The Role of Therapeutic Drug Monitoring of Imatinib in Patients with Chronic Myeloid Leukemia and Metastatic or Unresectable Gastrointestinal Stromal Tumors-Reference-Cited by-同舟云学术

The Role of Therapeutic Drug Monitoring of Imatinib in Patients with Chronic Myeloid Leukemia and Metastatic or Unresectable Gastrointestinal Stromal Tumors

Published:2012-02 Issue:1 Volume:34 Page:85-97
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:

Author:

Teng Jennifer F T,Mabasa Vincent H,Ensom Mary H H

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference64 articles.

1. Clinical pharmacokinetics of imatinib.;Peng;Clin Pharmacokinet,2005

2. Chronic myeloid leukemiaadvances in biology and new approaches to treatment.;Goldman;N Engl J Med,2003

3. Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet.;Baccarani;Blood,2006

4. Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet.;Baccarani;J Clin Oncol,2009

5. The epidemiology of malignant gastrointestinal stromal tumors: an analysis of 1,458 cases from 1992 to 2000.;Tran;Am J Gastroenterol,2005

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of an hollow fiber solid phase microextraction method for the analysis of unbound fraction of imatinib and N-desmethyl imatinib in human plasma;Journal of Pharmaceutical and Biomedical Analysis;2024-11

2. Contribution of the α₁-Acid Glycoprotein in Drug Pharmacokinetics: The Usefulness of α₁-Acid Glycoprotein-Knockout Mice;Molecular Pharmaceutics;2024-06-11

3. Predictive performance of population pharmacokinetic models of imatinib in chronic myeloid leukemia patients;Cancer Chemotherapy and Pharmacology;2024-03-05

4. Advanced gastrointestinal stromal tumor: reliable classification of imatinib plasma trough concentration via machine learning;BMC Cancer;2024-02-24

5. Therapeutic Drug Monitoring of Imatinib and N‐Desmethyl Imatinib in Chronic Myeloid Leukemia Patients Using LC‐MS/MS in a Cohort Study;The Journal of Clinical Pharmacology;2023-09